Cytosorbents (CTSO) Cost of Revenue (2011 - 2026)
Cytosorbents' (CTSO) quarterly Cost of Revenue came in at $2.7 million in Q1 2026, up 959.69% YoY from $258000.0 in Q1 2025, and up 12.51% on a QoQ basis from $2.4 million in Q4 2025.
Cytosorbents (CTSO) Cost of Revenue (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 16 years of Cost of Revenue data on file, last reported at $2.7 million in Q1 2026.
- Quarterly Cost of Revenue rose 959.69% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.8 million (up 21.88% YoY) and the FY2025 annual result came in at $10.6 million, down 1.27% from the prior year.
- Cost of Revenue grew to $2.7 million in Q1 2026, from $2.4 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $4.5 million in Q3 2022 to a low of -$9.9 million in Q4 2022.
- A 5-year average of $1.8 million and a median of $2.4 million in 2025 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue tumbled 415.68% — and 2026, when it jumped 959.69%.
- Tracing CTSO's Cost of Revenue over 5 years: stood at -$9.9 million in 2022, then jumped by 123.8% to $2.3 million in 2023, then rose by 23.42% to $2.9 million in 2024, then retreated by 16.09% to $2.4 million in 2025, then climbed by 12.51% to $2.7 million in 2026.
- The last three Cost of Revenue figures came in at $2.7 million (Q1 2026), $2.4 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Cytosorbents | 23.59 Mn | 19.18 Mn | 7.05 Mn | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.58 Mn |
| Jun 30, 2026 | 2.58 Mn |
| Mar 31, 2026 | 2.73 Mn |
| Mar 31, 2026 | 2.73 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | 258,000.00 |
| Mar 31, 2025 | 258,000.00 |
| Dec 31, 2024 | 2.90 Mn |
| Dec 31, 2024 | 2.90 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Jun 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 2.34 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.12 Mn |